EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Diagnoses of Multiple Sclerosis and Related Disorders and Disease‐Modifying Therapies: A Comparison of the Danish Multiple Sclerosis Registry With Other Danish Health Registries

Hanna Joensen, Elisabeth Framke, Luigi Pontieri, Melinda Magyari

Brain and Behavior · 2026

DOI: 10.1002/brb3.71235 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Brain and Behavior, 2026. Verfasst von Hanna Joensen und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark. Hauptthemen laut MEDLINE: Registries, Multiple Sclerosis. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Comparison of recorded diagnoses of multiple sclerosis (MS) and related disorders and disease‐modifying therapies (DMTs) in The Danish Multiple Sclerosis Registry (DMSR) with other nationwide health registries. The aim of the study is to describe and compare information on diagnoses of MS and related disorders and treatments with DMTs available in three national registries, highlighting the key differences relevant to MS research and providing insight for researchers for their choice of data source(s) suitable for their study. Materials and Methods DMSR is a disease registry encompassing information on persons with MS and related disorders. The Danish National Patient Registry (DNPR) is a registry of activities at Danish hospitals. The Danish National Hospital Medication Registry (DNHMR) contains information on in‐hospital prescription medications. The population comprised all persons in DMSR in 2023 who were alive or born after and residing in Denmark on January 1, 1995 (N = 26,474). For this population, we identified DNPR contacts with diagnoses of MS or related disorders and initiated DMTs in DNHMR. Diagnostic and demographic characteristics were reported as recorded in DMSR for the total population, and the subset included in DMSR but not in DNPR. Characteristics of the part of the population identified in DNPR were reported as recorded in DNPR. We calculated the proportions of DMT treatments in DMSR identified in DNHMR.

Results

Of the 26,474 persons, 23,857 (90.1%) were recorded with a diagnosis of MS or a related disorder in DNPR. Most (86.6%) of the 2617 persons not identified in DNPR were diagnosed before 1995. The proportion of persons with MS recorded without specification of the disease phenotype was 23.5% in the DMSR and 76.2% in the DNPR. After 2005, only 1.8% of persons with MS were recorded with an unspecified phenotype in DMSR. Of a total of 18,168 initiated DMT treatments in DMSR, 7230 (39.8%) were identified in DNHMR, with proportions ranging from 0.0% (mitoxantrone) to 88.5% (ocrelizumab).

Conclusions

DMSR is suitable for disease‐specific research addressing treatment efficacy, disease development, and long‐term outcomes. In contrast, DNPR is well suited for broad epidemiological studies involving various health conditions and hospital utilization. The DNHMR will, when matured, be useful for studies involving medical treatment and comedication. However, as each registry has limitations, for most studies the best approach will be combining registries, depending on the research question.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesMultiple SclerosisHumansDenmarkFemaleMaleAdultMiddle AgedAdolescentYoung AdultAged

Stichwörter der Autor:innen

diagnosesdisease‐modifying treatmentmultiple sclerosisnationwideregistries

Autor:innen und Institutionen

  • The Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.
  • Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Zitieren

APA

Joensen, H., Framke, E., Pontieri, L., & Magyari, M. (2026). Diagnoses of Multiple Sclerosis and Related Disorders and Disease‐Modifying Therapies: A Comparison of the Danish Multiple Sclerosis Registry With Other Danish Health Registries. Brain and Behavior. https://doi.org/10.1002/brb3.71235

Vancouver

Joensen H, Framke E, Pontieri L, Magyari M. Diagnoses of Multiple Sclerosis and Related Disorders and Disease‐Modifying Therapies: A Comparison of the Danish Multiple Sclerosis Registry With Other Danish Health Registries. Brain and Behavior. 2026. doi:10.1002/brb3.71235

BibTeX
@article{Joensen2026,
  author = {Joensen, Hanna and Framke, Elisabeth and Pontieri, Luigi and Magyari, Melinda},
  title = {Diagnoses of Multiple Sclerosis and Related Disorders and Disease‐Modifying Therapies: A Comparison of the Danish Multiple Sclerosis Registry With Other Danish Health Registries},
  journal = {Brain and Behavior},
  year = {2026},
  doi = {10.1002/brb3.71235}
}
Kostenlos starten →